Theragenics Brachytherapy to Attend the 2026 LUGPA Annual Meeting

November 5–7, 2026 | Chicago Marriott Magnificent Mile | Chicago, IL

Theragenics Brachytherapy is pleased to participate in the 2026 LUGPA Annual Meeting, November 5–7 in Chicago.

We look forward to connecting with urology practice leaders and physicians to discuss the continued role of low-dose-rate (LDR) brachytherapy in prostate cancer care, including opportunities to expand patient treatment options through community-based and ASC programs.

To register and more information visit: https://www.lugpa.org/annual